News & Updates
Filter by Specialty:
Lumateperone improves depression symptoms in bipolar disorder
26 Dec 2021
Treatment with 42-mg lumateperone daily leads to significant improvement in depression symptoms, with no serious safety issues, among patients with major depressive episodes associated with both bipolar I and II disorders, a study has shown.
Lumateperone improves depression symptoms in bipolar disorder
26 Dec 2021Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021
For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.